Comparison
Why is RenovoRx, Inc. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 17.87% and Operating profit at -193.17% over the last 5 years
2
Positive results in Jun 26
- NET SALES(HY) Higher at USD 1.47 MM
- NET PROFIT(HY) Higher at USD -6.69 MM
- RAW MATERIAL COST(Y) Fallen by -32.22% (YoY)
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 32.52%, its profits have fallen by -14%
4
High Institutional Holdings at 31.25%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
5
Market Beating Performance
- The stock has generated a return of 32.52% in the last 1 year, much higher than market (S&P 500) returns of 15.76%
How much should you hold?
- Overall Portfolio exposure to RenovoRx, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is RenovoRx, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
RenovoRx, Inc.
32.52%
0.64
90.42%
S&P 500
15.76%
1.20
13.17%
Quality key factors
Factor
Value
Sales Growth (5y)
17.87%
EBIT Growth (5y)
-193.17%
EBIT to Interest (avg)
-10.06
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.10
Sales to Capital Employed (avg)
0.05
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
35.53%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.13
EV to EBIT
-2.71
EV to EBITDA
-2.71
EV to Capital Employed
-16.88
EV to Sales
31.47
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-138.44%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Technical Movement
16What is working for the Company
NET SALES(HY)
Higher at USD 1.47 MM
NET PROFIT(HY)
Higher at USD -6.69 MM
RAW MATERIAL COST(Y)
Fallen by -32.22% (YoY
EPS(Q)
Highest at USD -0.06
-8What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -11.87 MM
DEBT-EQUITY RATIO
(HY)
Highest at -101.23 %
PRE-TAX PROFIT(Q)
Fallen at -28.13%
NET PROFIT(Q)
Fallen at -28.13%
Here's what is working for RenovoRx, Inc.
Net Sales
At USD 1.47 MM has Grown at 137.8%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Net Sales
Higher at USD 1.47 MM
than preceding 12 month period ended Jun 2026MOJO Watch
In the half year the company has already crossed sales of the previous twelve months
Net Sales (USD MM)
EPS
Highest at USD -0.06
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Raw Material Cost
Fallen by -32.22% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for RenovoRx, Inc.
Operating Cash Flow
Lowest at USD -11.87 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Pre-Tax Profit
Fallen at -28.13%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Fallen at -28.13%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Debt-Equity Ratio
Highest at -101.23 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Footer loading






